PTGS2 and colorectal carcinoma: In has been demonstrated, in fact, that high expression of cyclooxygenase-2 (COX-2) in the 50% of colorectal adenomas and in up to 85% of adenocarcinomas correlates with poor survival of CRC patients [125].